Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001653152 | SCV001871354 | likely benign | not provided | 2021-02-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002073054 | SCV002400085 | likely benign | Osteogenesis imperfecta type I | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002405273 | SCV002714385 | likely benign | Cardiovascular phenotype | 2019-06-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005237946 | SCV005883045 | benign | not specified | 2024-12-06 | criteria provided, single submitter | clinical testing |